Your browser doesn't support javascript.
Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study.
Kirwan, Peter D; Charlett, Andre; Birrell, Paul; Elgohari, Suzanne; Hope, Russell; Mandal, Sema; De Angelis, Daniela; Presanis, Anne M.
  • Kirwan PD; Medical Research Council Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK. peter.kirwan@mrc-bsu.cam.ac.uk.
  • Charlett A; UK Health Security Agency, London, UK.
  • Birrell P; Medical Research Council Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Elgohari S; UK Health Security Agency, London, UK.
  • Hope R; UK Health Security Agency, London, UK.
  • Mandal S; UK Health Security Agency, London, UK.
  • De Angelis D; UK Health Security Agency, London, UK.
  • Presanis AM; Medical Research Council Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Nat Commun ; 13(1): 4834, 2022 08 17.
Article in English | MEDLINE | ID: covidwho-1991592
ABSTRACT
Widespread vaccination campaigns have changed the landscape for COVID-19, vastly altering symptoms and reducing morbidity and mortality. We estimate trends in mortality by month of admission and vaccination status among those hospitalised with COVID-19 in England between March 2020 to September 2021, controlling for demographic factors and hospital load. Among 259,727 hospitalised COVID-19 cases, 51,948 (20.0%) experienced mortality in hospital. Hospitalised fatality risk ranged from 40.3% (95% confidence interval 39.4-41.3%) in March 2020 to 8.1% (7.2-9.0%) in June 2021. Older individuals and those with multiple co-morbidities were more likely to die or else experienced longer stays prior to discharge. Compared to unvaccinated people, the hazard of hospitalised mortality was 0.71 (0.67-0.77) with a first vaccine dose, and 0.56 (0.52-0.61) with a second vaccine dose. Compared to hospital load at 0-20% of the busiest week, the hazard of hospitalised mortality during periods of peak load (90-100%), was 1.23 (1.12-1.34). The prognosis for people hospitalised with COVID-19 in England has varied substantially throughout the pandemic and according to case-mix, vaccination, and hospital load. Our estimates provide an indication for demands on hospital resources, and the relationship between hospital burden and outcomes.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-32458-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S41467-022-32458-y